AILEEN JIRAS: Open Payments
NPI 1063054641 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$446 in 20 payments from 7 companies in 2025. Trend: 2023 $769 · 2024 $991 · 2025 $446
Food & beverage: $446
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 9 | $213 |
| Novartis Pharmaceuticals Corporation | 4 | $68 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $38 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| Regeneron Healthcare Solutions, Inc. | 1 | $33 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| ABIOMED | 1 | $28 |
Products named: VYNDAQEL, LEQVIO, LifeVest, JARDIANCE, ELIQUIS, EVKEEZA, WAINUA.
Industry payments across CA — which companies pay providers there.
